Tech Company Financing Transactions

Galera Therapeutics Funding Round

On 11/29/2016, Galera Therapeutics raised $15 million in Series B investment from Sofinnova Ventures.

Transaction Overview

Announced On
11/29/2016
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series B
Investors

Sofinnova Ventures (Mike Powell)

Proceeds Purpose
The proceeds from the financing will be used to prepare the Company's lead product candidate, GC4419, for Phase 3 registration studies.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
2 West Liberty Blvd. 110
Malvern, PA 19355
USA
Email Address
Not Recorded
Overview
Galera Therapeutics (Nasdaq: GRTX) develops therapeutic agents for preventing damage to normal tissues during the radiation treatment of cancer.
Profile
Galera Therapeutics LinkedIn Company Profile
Social Media
Galera Therapeutics Company Twitter Account
Company News
Galera Therapeutics News
Facebook
Galera Therapeutics on Facebook
YouTube
Galera Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Mel Sorensen
  Mel Sorensen LinkedIn Profile  Mel Sorensen Twitter Account  Mel Sorensen News  Mel Sorensen on Facebook
Chief Financial Officer
Joel Sussman
  Joel Sussman LinkedIn Profile  Joel Sussman Twitter Account  Joel Sussman News  Joel Sussman on Facebook
Chief Medical Officer
Jon Holmlund
  Jon Holmlund LinkedIn Profile  Jon Holmlund Twitter Account  Jon Holmlund News  Jon Holmlund on Facebook
Chief Operating Officer
Robert Beardsley
  Robert Beardsley LinkedIn Profile  Robert Beardsley Twitter Account  Robert Beardsley News  Robert Beardsley on Facebook
Chief Scientific Officer
Dennis Riley
  Dennis Riley LinkedIn Profile  Dennis Riley Twitter Account  Dennis Riley News  Dennis Riley on Facebook
VP - Bus. Development
Arthur Fratamico
  Arthur Fratamico LinkedIn Profile  Arthur Fratamico Twitter Account  Arthur Fratamico News  Arthur Fratamico on Facebook
VP - Bus. Development
Stephen Ross
  Stephen Ross LinkedIn Profile  Stephen Ross Twitter Account  Stephen Ross News  Stephen Ross on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/29/2016: TermScout venture capital transaction
Next: 11/29/2016: AvidXchange venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary